alexa The Potential of Intralesional Rose Bengal to Stimulate
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses

Ajay V Maker1,2*, Bellur Prabhakar2 and Krunal Pardiwala1
1Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, Chicago Illinois, USA
2Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago Illinois, USA
Corresponding Author : Ajay V Maker, MD, FACS
Division of Surgical Oncology
Department of Surgery
University of Illinois at Chicago
Chicago Illinois, USA
Tel: 773-296-7379
E-mail: [email protected]
Received: April 23, 2015 Accepted: July 15, 2015 Published: July 22, 2015
Citation: Maker AV, Prabhakar B, Pardiwala K (2015) The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses. J Clin Cell Immunol 6:343. doi:10.4172/2155-9899.1000343
Copyright: © 2015 Maker AV, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google


Rose Bengal (RB) is a red synthetic dye that was initially used in the garment industry and has been used safely for decades as a corneal stain by ophthalmologists. Antineoplastic properties of RB have also been observed, though the mechanism of action remained to be elucidated. Recently, interest in RB as a therapeutic cancer treatment has increased due to significant anti-tumor responses with direct tumor injection in human clinical trials for metastatic melanoma. In these patients, there has been the implication that RB may mount a T-cell mediated antitumor response and impart antigen-specific responses in distant bystander lesions. This article serves to evaluate the potential of intralesional rose bengal to stimulate T-cell mediated anti-tumor responses in in-vitro, pre-clinical, and clinical studies.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version